Camber Pharmaceuticals Adds Two Key Executives
Piscataway, NJ, July 20, 2014– Camber Pharmaceuticals, a leading generics drug supplier, is pleased to announce the addition of two key executives to its rapidly growing organization.
Amanda Rebnicky, Director of Sales Operations, brings over 10 years of generics industry experience holding positions of increasing responsibility in marketing and sales operations at Dr. Reddy’s Laboratories and Fougera Pharmaceuticals.
Kirk Hessels, Director of Marketing most recently served as Vice President of Vision Creative Group, a leading consumer packaged goods advertising agency and previously owned and operated his own integrated marketing agency, KH Advertising, for over 20 years.
“I am thrilled to add these two talented people to our organization” said Kon Ostaficiuk, President of Camber Pharmaceuticals. “Both Amanda and Kirk bring the
type of energy, creativity and strategic thinking that will help Camber continue to grow as we add new products and meet the challenges of the generics marketplace.”
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection





